Form 8-K - Current report:
SEC Accession No. 0001213900-15-009450
Filing Date
2015-12-14
Accepted
2015-12-14 08:51:47
Documents
2
Period of Report
2015-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121415_relmadatherap.htm 8-K 26947
2 PRESS RELEASE f8k121415ex99i_relmada.htm EX-99.1 19000
  Complete submission text file 0001213900-15-009450.txt   47116
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 151284857
SIC: 2834 Pharmaceutical Preparations